NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $17,848 | -98.9% | 194 | -98.9% | 0.00% | -100.0% |
| Q4 2022 | $1,584,788 | +49.5% | 17,469 | +25.3% | 0.00% | – |
| Q3 2022 | $1,060,000 | -1.2% | 13,946 | +9.8% | 0.00% | – |
| Q2 2022 | $1,073,000 | -5.5% | 12,699 | -1.9% | 0.00% | – |
| Q1 2022 | $1,136,000 | +780.6% | 12,951 | +825.1% | 0.00% | – |
| Q3 2015 | $129,000 | -6.5% | 1,400 | 0.0% | 0.00% | – |
| Q2 2015 | $138,000 | 0.0% | 1,400 | 0.0% | 0.00% | – |
| Q1 2015 | $138,000 | +6.2% | 1,400 | 0.0% | 0.00% | – |
| Q4 2014 | $130,000 | -1.5% | 1,400 | 0.0% | 0.00% | – |
| Q3 2014 | $132,000 | +3.9% | 1,400 | 0.0% | 0.00% | – |
| Q2 2014 | $127,000 | +6.7% | 1,400 | 0.0% | 0.00% | – |
| Q1 2014 | $119,000 | +5.3% | 1,400 | 0.0% | 0.00% | – |
| Q4 2013 | $113,000 | +5.6% | 1,400 | 0.0% | 0.00% | – |
| Q3 2013 | $107,000 | -86.5% | 1,400 | -87.5% | 0.00% | -100.0% |
| Q2 2013 | $792,000 | – | 11,205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |